Changes in TNF-α mRNA levels in the peripheral blood of patients with chronic hepatitis C virus (HCV) infection during α-interferon and ribavirin therapy

Viral Immunology

Volumn 17, Issue 4, 2004, Pages 580-587

  Sypniewski, Daniel ^a   Jurzak, Magdalena ^a   Cholewa, Krzysztof ^a   Gola, Joanna ^a   Mazurek, Urszula ^a   Wilczok, Tadeusz ^a   Rozek Kostórkiewicz, Justyna ^a   Mazur, Włodzimierz ^a   Gonciarz, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; MESSENGER RNA; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 11144245106     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2004.17.580     Document Type: Article

References (40)

1. Ando, K., K. Hiroishi, T. Kaneko, et al. 1997. Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J. Immunol. 158:5283-5291.
2. Bednarek, I., U. Mazurek, E. Moric, et al. 1997. Replicating hepatitis C virus in peripheral blood mononuclear cells. Med. Sci. Monit. 3:313-318.
3. Bird, G., N. Sheron, J. Goka, et al. 1990. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann. Intern. Med. 112:917-920.
4. Borden, E.C., J. Waalen, R. Schreiber, et al. 1995. Response and resistance to interferons and interacting cytokines. J. Natl. Cancer Inst. 87:257-64.
5. Calabrese, F., P. Pontisso, E. Pettenazzo, et al. 2000. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology 31:1153-1159.
6. Chang, K., B. Rehermann, J. McHutchinson, et al. 1997. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J. Clin. Invest. 100:2376-2385.
7. Chisari, F.V. 1997. Cytotoxic T cells and viral hepatitis. J. Clin. Invest. 99:1472-1477.
8. Chomczynski, P., and N. Sacchi. 1987. A single-step method of RNA extraction and purification. Anal. Biochem. 162:156-159.
9. Cramp, M.E., S. Rossol, S. Chokshi, et al. 2000. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 118:346-55.
10. Diez-Ruiz, A., G.P. Tilz, F. Gutierrez-Gea, et al. 1995. Neopterin and soluble tumor necrosis factor receptor type I in alcohol-induced cirrhosis. Hepatology 21:976-978.
11. Frese, M., K. Barth, V. Kaul, et al. 2003. Hepatitis C virus RNA replication is resistant to tumour necrosis factor-α. J. Gen. Virol. 84:1253-1259.
12. Gonzales-Amaro, R., C. Garcia-Monzon, L. Garcia-Buey, et al. 1994. Induction of tumor necrosis factor a production by human hepatocytes in chronic viral hepatitis. J. Exp. Med. 179:841-848.
13. Gonzales-Peralta, R., G.L. Davis, and J.Y. Lau. 1994. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J. Hepatol. 21:255-259.
14. + T-cell response against hepatitis C virus. Viral Immunol. 15: 121-133.
15. Itoh, Y., T. Okanoue, N. Ohnishi, et al. 1999. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 94:1332-1340.
16. Kishihara, Y., J. Hayashi, E. Yoshimura, et al. 1996. IL-1β and TNF-α produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C. Dig. Dis. Sci. 41:315-321.
17. Larrea, E., N. Garcia, C. Qian, et al. 1996. Tumor necrosis factor-α gene expression and the response to interferon in chronic hepatitis C. Hepatology 23:210-216.
18. Lau, J.Y. 1998. Mechanisms of hepatic toxicity IV. Pathogenetic mechanisms involved in hepatitis C virus-induced liver diseases. Am. J. Physiol. 275:G1217-G1220.
19. Lau, J.Y., N. Sheron, K.T. Nouri-Aria, et al. 1991. Increased tumor necrosis factor-α receptor number in chronic hepatitis B virus infection. Hepatology 14:44-50.
20. Marinos, G., N.V. Naoumov, S. Rossol, et al. 1995. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. Gastroenterology 108:1453-1463.
21. McHutchinson, J.G., and T. Poynard. 1999. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin. Liver Dis. 19(Suppl. I):57-65.
22. Minami, M., M. Kita, X. Yan, et al. 2002. Role of IFN-γ and tumor necrosis factor-α in herpes simplex virus type I infection. J. Interf. Cyt. Res. 22:671-677.
23. Napoli, J., G.A. Bishop, P.H. McGuinness, et al. 1996. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology 24:759-765.
24. Navas, S., J. Castillo, J. Bartolome, et al. 1994. Positive and negative hepatitis C virus RNA strands in serum, liver and peripheral blood mononuclear cells in anti-HCV patients: relation with the liver lesion. J. Hepatol. 21:182-186.
25. Nelson, D.R., H.L. Lim, C.G. Marousis, et al. 1997. Activation of tumor necrosis factor-α system in chronic hepatitis C virus infection. Dig. Dis. Sci. 42: 2487-2494.
26. Nelson, D.R., C.G. Marousis, G.L. Davis, et al. 1997. The role of intrahepatic HCV-specific cytotoxic T cell lymphocytes in chronic hepatitis C. J. Immunol. 158: 1473-1481.
27. Neuman, M.G., J.P. Benhamou, M. Martinot, et al. 1999. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. Clin. Biochem. 32: 537-554.
28. Ning, Q., D. Brown, J. Parodo, et al. 1998. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J. Immunol. 160:3487-3493.
29. Podevin, P., J. Guechot, L. Serfaty, et al. 1997. Evidence for a deficiency of interferon response in mononuclear cells from hepatitis C viremic patients. J. Hepatol. 27:265-271.
30. Purcell, R. 1997. The hepatitis C virus: overview. Hepatology 26:11-14.
31. Ray, R.B., K. Meyer, R. Steele, et al. 1998. Inhibition of tumor necrosis factor (TNF-α)-mediated apoptosis by hepatitis C virus core protein. J. Biol. Chem. 273:2256-2259.
32. Rodriguez-Inigo, E., J. Bartolome, S. de Lucas, et al. 1999. Histological damage in chronic hepatitis C is not related to the extent of infection in the liver. Am. J. Pathol. 154:1877-1881.
33. Shapiro, S., V. Gershtein, N. Elias, et al. 1998. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-α) treatment. Clin. Exp. Immunol. 114:55-60.
34. Smyth, M.J., and J.A. Trapani. 1998. The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiology. J. Virol. 72:1-9.
35. Takii, T., C. Abe, A. Tamura, et al. 2001. Interleukin-1 or tumor necrosis factor-a augmented the cytotoxic effect of Mycobacteria on human fibroblasts: application of evaluation of pathogenesis of clinical isolates of Mycobacterium tuberculosis and M. avium complex. J. Interf. Cyt. Res. 21:187-197.
36. Tilg, H., W. Vogel, and C. Dinarello. 1995. Interferon-α induces circulating tumor necrosis factor receptor p55 in humans. Blood 85:433-435.
37. Tracey, K.J., and A. Cerami. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45:491-503.
38. Vilĉek, J., and T.H. Lee. 1991. Tumor necrosis factor. New insight into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266:7313-7316.
39. Wong, G.H., and D.V. Goeddel. 1986. Tumor necrosis alpha and beta inhibit virus replication and synergize with interferon. Nature 323:816-822.
40. Zhu, N., A. Khoshnan, R. Schneider, et al. 1998. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virol. 72:3691-3697.